Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- Restylane Volyme for Correction of Midface Volume Deficit and/or Midface Contour Deficiency: Complete Statistical AnalysisIndependent statistical analysis of Restylane Volyme for Correction of Midface Volume Deficit and/or Midface Contour Deficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Resurgence as Choice: Basic and Clinical Studies: Complete Statistical AnalysisIndependent statistical analysis of Resurgence as Choice: Basic and Clinical Studies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03423940).
- Resuscitation Outcomes Consortium (ROC) Prehospital Resuscitation Using an Impedance Valve: Complete Statistical AnalysisIndependent statistical analysis of Resuscitation Outcomes Consortium (ROC) Prehospital Resuscitation Using an Impedance Valve: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00394706).
- Resuscitation With Plasma in Surgical and Trauma Patients With Septic Shock: Complete Statistical AnalysisIndependent statistical analysis of Resuscitation With Plasma in Surgical and Trauma Patients With Septic Shock: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ResvEndoIndependent statistical analysis of Resveratrol for Pain Due to Endometriosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02475564).
- REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE): Complete Statistical AnalysisIndependent statistical analysis of REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00271154).
- RETAINIndependent statistical analysis of Efficacy and Safety of Ranibizumab in Two "Treat and Extend" Treatment Algorithms Versus Ranibizumab As Needed in Patients With Macular Edema and Visual Impairment Secondary to Diabetes Mellitus:…
- RETAINIndependent statistical analysis of Extended Follow-up of Patients With Macular Edema Due to Retinal Vein Occlusion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Retapamulin Ointment in Healthy Adults Nasally Colonized With Staphylococcus Aureus: Complete Statistical AnalysisIndependent statistical analysis of Retapamulin Ointment in Healthy Adults Nasally Colonized With Staphylococcus Aureus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00539994).
- RETHINCIndependent statistical analysis of RETHINC: REdefining THerapy In Early COPD for the Pulmonary Trials Cooperative: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ReTHINKIndependent statistical analysis of Phase III Study Investigating the Efficacy and Safety of Ruxolitinib in Early Myelofibrosis Patients With High Molecular Risk Mutations.: primary endpoint results, effect estimate with confidence interval, sample-size…
- Retreatment of Dialysis Patients With Chronic Hepatitis C With Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin: Complete Statistical AnalysisIndependent statistical analysis of Retreatment of Dialysis Patients With Chronic Hepatitis C With Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Retrieval-Based Word Learning in Developmental Language Disorder During Book Reading: Complete Statistical AnalysisIndependent statistical analysis of Retrieval-Based Word Learning in Developmental Language Disorder During Book Reading: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06026124).
- RETRIEVE-AMIIndependent statistical analysis of RETRIEVE-AMI Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05307965).
- Retrospective Chart Review Study to Assess Characteristics, Treatment Outcomes and Resource Use of Adults Hospitalized for CAP and CSSTi Treated With Zinforo in Multiple Countries: Complete Statistical AnalysisIndependent statistical analysis of Retrospective Chart Review Study to Assess Characteristics, Treatment Outcomes and Resource Use of Adults Hospitalized for CAP and CSSTi Treated With Zinforo in Multiple Countries: primary endpoint results,…
- Retrospective Data Collection Study in Patients Receiving Two or More OZURDEX® Injections for Macular Oedema Secondary to Retinal Vein Occlusion: Complete Statistical AnalysisIndependent statistical analysis of Retrospective Data Collection Study in Patients Receiving Two or More OZURDEX® Injections for Macular Oedema Secondary to Retinal Vein Occlusion: primary endpoint results, effect estimate with confidence interval,…
- Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX®: Complete Statistical AnalysisIndependent statistical analysis of Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX®: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Retrospective Encore Reverse Shoulder Prosthesis Study: Complete Statistical AnalysisIndependent statistical analysis of Retrospective Encore Reverse Shoulder Prosthesis Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00765037).
- Retrospective Evaluation of Performance of Coflex® Interlaminer Technology Versus Decompression With or Without Fusion: Complete Statistical AnalysisIndependent statistical analysis of Retrospective Evaluation of Performance of Coflex® Interlaminer Technology Versus Decompression With or Without Fusion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Retrospective Observational Study To Update 5-Year Survival Of Subjects Who Participated In Axitinib Trial A4061012: Complete Statistical AnalysisIndependent statistical analysis of Retrospective Observational Study To Update 5-Year Survival Of Subjects Who Participated In Axitinib Trial A4061012: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Retrospective Post-Market Clinical Follow-Up Study of GORE-TEX® Vascular Grafts and GORE® PROPATEN® Vascular Graft in Peripheral Artery Disease, Aortic Aneurysms, and Dialysis Access: Complete Statistical AnalysisIndependent statistical analysis of Retrospective Post-Market Clinical Follow-Up Study of GORE-TEX® Vascular Grafts and GORE® PROPATEN® Vascular Graft in Peripheral Artery Disease, Aortic Aneurysms, and Dialysis Access: primary endpoint results, effect estimate…
- Retrospective Study Chimaera Long Nail in Adult Patient: Complete Statistical AnalysisIndependent statistical analysis of Retrospective Study Chimaera Long Nail in Adult Patient: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06285981).
- Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions: Complete Statistical AnalysisIndependent statistical analysis of Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Retrospective Study on Referral Patterns for High Risk Patients Post Nephrectomy: Complete Statistical AnalysisIndependent statistical analysis of Retrospective Study on Referral Patterns for High Risk Patients Post Nephrectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- RetroTIFIndependent statistical analysis of Retrospective TIF Study for Treatment of Gastroesophageal Reflux Disease (GERD). The RetroTIF Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Return of First-phase Insulin Secretion in Type 2 Diabetes is Associated With Depletion of Pancreas Lipid: Complete Statistical AnalysisIndependent statistical analysis of Return of First-phase Insulin Secretion in Type 2 Diabetes is Associated With Depletion of Pancreas Lipid: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- rev/abraxaneIndependent statistical analysis of Phase I/II Trial of the Combination of Lenalidomide (Revlimid) and Nab-paclitaxel (Abraxane) in the Treatment of Relapsed/Refractory Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size…
- Revaccination With Influenza Vaccine GSK1247446A: Complete Statistical AnalysisIndependent statistical analysis of Revaccination With Influenza Vaccine GSK1247446A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00545025).
- Revaccination With PNEUMOVAX(TM) 23 in Older Adults (V110-007): Complete Statistical AnalysisIndependent statistical analysis of Revaccination With PNEUMOVAX(TM) 23 in Older Adults (V110-007): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00560950).
- REVEALIndependent statistical analysis of Evaluation of AMG 714 for Vitiligo: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04338581).
- REVEALIndependent statistical analysis of REVEAL III: Risk Evaluation and Education for Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00462917).
- REVEALIndependent statistical analysis of REVEAL: Randomized EValuation of the Effects of Anacetrapib Through Lipid-modification: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01252953).
- REVEALIndependent statistical analysis of Revolution™ Peripheral Atherectomy System for Lower Extremity Peripheral Arterial Revascularization: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02961894).
- REVEAL 1Independent statistical analysis of REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Reveal In-Office Implants: Complete Statistical AnalysisIndependent statistical analysis of Reveal In-Office Implants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01168427).
- Reveal LINQ for Chronic Obstructive Pulmonary Disease (COPD): Complete Statistical AnalysisIndependent statistical analysis of Reveal LINQ for Chronic Obstructive Pulmonary Disease (COPD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04169529).
- REVEALPLAQUEIndependent statistical analysis of The REVEALPLAQUE Study: A pRospEctiVe, multicEnter Study to AnaLyze PLAQUE Using CCTA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- REVELUTIONIndependent statistical analysis of RElugolix VErsus LeUprolide Cardiac Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05320406).
- REVERCEIndependent statistical analysis of the REVERCE phase 2 trial evaluating regorafenib with cetuximab or panitumumab-based treatment in colorectal cancer, including trial design, time-to-event endpoints, log-rank methodology, reported P-values, safety, and statistical interpretation.
- Reversal of Dabigatran Anticoagulant Effect With Idarucizumab: Complete Statistical AnalysisIndependent statistical analysis of Reversal of Dabigatran Anticoagulant Effect With Idarucizumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02104947).
- Reversal of Hepatic Impairment in Patients With Hepatitis C Virus (HCV) and Early Decompensation of Cirrhosis: Complete Statistical AnalysisIndependent statistical analysis of Reversal of Hepatic Impairment in Patients With Hepatitis C Virus (HCV) and Early Decompensation of Cirrhosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- REVERSEIndependent statistical analysis of Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Reverse Medical Barrel™ Device for Adjunctive Treatment for Wide-Neck, Intracranial, Bifurcating/Branching Aneurysms: Complete Statistical AnalysisIndependent statistical analysis of Reverse Medical Barrel™ Device for Adjunctive Treatment for Wide-Neck, Intracranial, Bifurcating/Branching Aneurysms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib: Complete Statistical AnalysisIndependent statistical analysis of Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01466972).
- Reversing Synchronized Brain Circuits With Targeted Auditory-Somatosensory Stimulation to Treat Phantom Percepts: Complete Statistical AnalysisIndependent statistical analysis of Reversing Synchronized Brain Circuits With Targeted Auditory-Somatosensory Stimulation to Treat Phantom Percepts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Reversing Ticagrelor’s Effects With Fresh Platelets: Complete Statistical AnalysisIndependent statistical analysis of Reversing Ticagrelor's Effects With Fresh Platelets: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02201394).
- REVIRAL 1Independent statistical analysis of A Study to Learn About the Effects of Sisunatovir in Infants With Respiratory Syncytial Virus Lower Respiratory Tract Infection.: primary endpoint results, effect estimate with confidence interval, sample-size…
- Revitalize Cognition: Near Infrared Stimulation in Older Adults: Complete Statistical AnalysisIndependent statistical analysis of Revitalize Cognition: Near Infrared Stimulation in Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02582593).
- Revlimid in Transfusion Dependent Patients: Complete Statistical AnalysisIndependent statistical analysis of Revlimid in Transfusion Dependent Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01178814).
- Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01600053).